A detailed history of Whitefort Capital Management, LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Whitefort Capital Management, LP holds 2,391,000 shares of ROIV stock, worth $27.7 Million. This represents 14.67% of its overall portfolio holdings.

Number of Shares
2,391,000
Previous 2,391,000 -0.0%
Holding current value
$27.7 Million
Previous $25.3 Million 9.18%
% of portfolio
14.67%
Previous 19.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $7.9 Million - $9.44 Million
800,000 Added 50.28%
2,391,000 $25.2 Million
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $13.3 Million - $18.4 Million
1,591,000 New
1,591,000 $17.9 Million
Q1 2023

May 12, 2023

SELL
$6.92 - $9.98 $3.98 Million - $5.74 Million
-575,000 Reduced 40.82%
833,471 $6.15 Million
Q4 2022

Feb 14, 2023

BUY
$3.36 - $7.99 $4.73 Million - $11.3 Million
1,408,471 New
1,408,471 $11.3 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Whitefort Capital Management, LP Portfolio

Follow Whitefort Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitefort Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Whitefort Capital Management, LP with notifications on news.